CCHR: Antidepressants—Addiction and Withdrawal
CCHR: Antidepressants—Addiction and Withdrawal – www.cchrint.org Karen Barth Menzies, speaking about Paxil/antidepressant addiction and withdrawal. Menzies has been on the forefront of the SSRI antidepressant litigation for more than a decade against defendants such as, GlaxoSmithKline, Pfizer and Eli Lilly in cases involving antidepressant-induced suicide, withdrawal and birth defects. In 2003, she was appointed Lead Counsel for the Plaintiffs’ Steering Committee in the Paxil Products Liability Litigation.. She was appointed co-liaison counsel in the Paxil birth defect case in Philadelphia, Pennsylvania. Karen has testified twice before FDA advisory boards as well as the California State Legislature on the safety concerns regarding the SSRI antidepressants and the manufacturers’ misconduct. For studies and warnings on antidepressants (including addiction and withdrawal) visit www.cchrint.org
Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 …
Filed under: addiction side effects
… a GABA aminotransferase inhibitor), which Catalyst plans to develop for the treatment of cocaine addiction and Tourette's Disorder, CPP-115, another GABA aminotransferase inhibitor that is more potent than vigabatrin and has reduced side effects (e …
Read more on NASDAQ
Painkiller and Lung Cancer Research Pays Off for California and Oregon …
Filed under: addiction side effects
Raghav Tripathi, a senior at Westview High School in Portland, Oregon, won the individual category and a $ 3,000 college scholarship for identifying a potential anti-inflammatory drug that may reduce the unintended side-effects and addiction associated …
Read more on Sacramento Bee
More Addiction Side Effects Information…